Attenuation of Smad2 activity shows resistance to TGF-β signalling in mammary adenocarcinoma (MCF-7) cells

Cell Biology International

Volumn 37, Issue 5, 2013, Pages 449-457

  Sengupta, Suman ^a,b   Kundu, Subhadip ^a,b   Bhattacharyya, Arindam ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b UNIVERSITY OF KALYANI   (India)

Author keywords

Breast cancer; Cdk2; Phospho linker Smad2; Smad2; TGF

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2 INHIBITOR; PROTEIN P21; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84878142686     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10061     Document Type: Article

References (28)

1. Alarcón C, Alexia-Ileana Z, Xi Q, Gao1 S, Yu Jianzhong, Sapkota G, Pan D, Massagué J, et al. (2009) CDK8/9 drive Smad transcriptional action, turnover and YAP interactions in BMP and TGFb pathways. Cell 139(4): 757-69.
2. Arnold A, Papanikolaou A (2005) Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 23: 4215-24.
3. Baughn LB, Di Liberto M, Niesvizky R, Cho HJ, Jayabalan D, Lane J, et al. (2009) CDK2 phosphorylation of Smad2 disrupts TGF-b transcriptional regulation in resistant primary bone marrow myeloma cells. J Immunol 182: 1810-17.
4. Besson A, Dowdy SF, Roberts JM (2008) CDK inhibitors: cell cycle regulators and beyond. Rev Dev Cell 14: 159-69.
5. Brattain MG, Ko Y, Banerji SS,Wu G,Willson JK, (1996) Defects of TGF-beta receptor signaling in mammary cell tumorigenesis. J Mammary Gland Biol Neoplasia 4: 365-72.
6. Chaudhury A, Howe PH (2009) The tale of transforming growth factor-beta (TGF-b) signaling. A Soigne Enigma Life 61: 929-39.
7. Chen-Kiang S, Hearn JC, Jayabalan D, Lane J, Liu F, Di Liberto M, Niesvizky R, (2009) CDK2 phosphorylation of Smad2 disrupts TGF-b transcriptional regulation in resistant primary bone marrow myeloma cells. J Immunol 82: 10- 1817.
8. Chytil A, Waltner-Law M, West R, Friedman D, Aakre M, et al. (2004) Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes. JBC 279: 47688-98.
9. Corsino P, Davis B, LawM, Chytil A, Forrester E, Nørgaard P, et al. (2007) Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor B resistance and acquire paracrine mitogenic stimulation during progression. Cancer Res 67: 3135-44.
10. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM, (2007) Integrating patterning signals: Wnt/ GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131: 980-93.
11. Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, Goerner N, et al. (2009) Ubiquitin ligase Nedd4L targets CDK8/9-activated Smad2/3 to end TGF-b signaling. Mol Cell 36: 57-468.
12. Grimm OH, Gurdon JB (2002) Nuclear exclusion of Smad2 is a mechanism leading to loss of competence. Nat Cell Biol 4: 519-22.
13. Kang JS, Liu C, Derynck R (2009) New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 19: 385-94.
14. Kretzschmar M, Doody J, Massagué J (1997) Opposing BMP and EGF signalling pathways converge on the TGF-b family mediator Smad1. Nature 389: 618-22.
15. Kretzschmar M, Doody J, Timokhina I, Massagué J (1999) A mechanism of repression of TGFb/Smad signaling by oncogenic Ras. Genes Dev 13: 804-16.
16. Massague J (2004) G1 cell-cycle control and cancer. Nature 432: 298-306.
17. Massague J (2008) TGF beta in cancer. Cell 134: 215-30.
18. Massagué J, Wotton D (2000) Transcriptional control by the TGF-b/Smad signaling system. EMBO J 19: 1745-54.
19. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F (2004) Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430: 226-31.
20. Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114: 4359-69.
21. Moustakas A, Kardassis D (1998) Regulation of the human p21yWAF1yCip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 95: 6733-8.
22. Pardali E, Ten DP (2009) Transforming growth factor-beta signaling and tumour angiogenesis. Front Biosci 14: 4848-61.
23. Pera EM, Ikeda A, Eivers E, De Robertis EM (2003) Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev 17: 3023-8.
24. Reiss M (1999) TGF-beta and cancer. Microbes Infect 1(15): 1327-47.
25. Sapkota G, Alarcón C, Spagnoli FM, Brivanlou AH, Massagué J (2007) Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25: 441-54.
26. Scandura JM, Boccuni P, Massague J, Nimer SD (2004) Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 101: 15231-6.
27. Wrighton KH, Lin X, Feng X-H (2008) Phospho-control of TGF-b superfamily signaling. Cell Res 19: 8-20.
28. Zelivianski S, Cooley A, Kall R, Jeruss JS (2010) Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in Cyclin D-overexpressing breast cancer cells. Mol Cancer Res 8: 1375-87.